"Founded in 1921, Bristol Hospital is the leading health provider for people who live and work in the Greater Bristol area. Proud of its achievements in service excellence, Bristol Hospital has earned national recognition for its commitment to providing outstanding patient care. Bristol Hospital has 154 licensed beds and offers a complete range of patient services including a first-rate emergency center that cares for more than 40,000 patients each year."

During the past decade, Bristol Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 7 clinical trials were completed, i.e. on average, 175% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bristol Hospital" #1 sponsor was "Pfizer" with 5 trials, followed by "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Bristol Hospital" with 1 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored and "National Cancer Institute (NCI)" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bristol Hospital" #1 collaborator was "NCIC Clinical Trials Group" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Bristol Hospital" are "Ulcerative Colitis" (4 trials), "Breast Cancer" (1 trials), "Colorectal Cancer" (1 trials), "Hypoxia" (1 trials) and "Nonalcoholic Fatty Liver Disease" (1 trials). Many other conditions were trialed in "Bristol Hospital" in a lesser frequency.

Most popular intervention types in "Bristol Hospital" are "Drug" (8 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "CP-690,500 5 mg" (1 trials), "CP-690,550" (1 trials), "CP-690,550 10 mg" (1 trials) and "CP690,550" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bristol Hospital" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Bristol Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Bristol Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Bristol Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".